Martin Redmon
Chief Tech/Sci/R&D Officer chez STEALTH BIOTHERAPEUTICS CORP
Profil
Martin P.
Redmon is currently the Chief Research & Development Officer at Stealth BioTherapeutics Corp.
He previously held the position of Senior Vice President-Research & Development at PreCision Dermatology, Inc. and Chief Research & Development Officer at Stealth BioTherapeutics, Inc. Dr. Redmon obtained undergraduate and doctorate degrees from the University of Kentucky.
Postes actifs de Martin Redmon
| Sociétés | Poste | Début |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Chief Tech/Sci/R&D Officer | 16/03/2021 |
Anciens postes connus de Martin Redmon
| Sociétés | Poste | Fin |
|---|---|---|
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Chief Tech/Sci/R&D Officer | - |
PreCision Dermatology, Inc.
 PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI. | Chief Tech/Sci/R&D Officer | - |
Formation de Martin Redmon
| University of Kentucky | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
PreCision Dermatology, Inc.
PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI. | Health Technology |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA. | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Health Technology |
